Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T0004 Safety Study in Port-Wine Stain
CTR20170377Phase 4Completed
- Sponsor
- Taizhou Fudan-Zhangjiang Pharmaceutical
- Start
- Apr 2017
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hemoporfin in port-wine stain, sponsored by Taizhou Fudan-Zhangjiang Pharmaceutical. Started Apr 2017; status: completed.
02
Drugs
hemoporfin
03
Conditions
port-wine stain
Beyond the preview
Go deeper on CTR20170377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170377.